Bhavya S. Doshi

752 total citations
28 papers, 518 citations indexed

About

Bhavya S. Doshi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Bhavya S. Doshi has authored 28 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Bhavya S. Doshi's work include Hemophilia Treatment and Research (12 papers), Platelet Disorders and Treatments (9 papers) and Virus-based gene therapy research (8 papers). Bhavya S. Doshi is often cited by papers focused on Hemophilia Treatment and Research (12 papers), Platelet Disorders and Treatments (9 papers) and Virus-based gene therapy research (8 papers). Bhavya S. Doshi collaborates with scholars based in United States, United Kingdom and Canada. Bhavya S. Doshi's co-authors include Valder R. Arruda, Benjamin J. Samelson‐Jones, Valder R. Arruda, Allyson M. Pishko, Shannon L. Meeks, Kandace Gollomp, Bagirath Gangadharan, Craig L. Bennett, G.W. Roberts and Jeremy M. Brown and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Bhavya S. Doshi

23 papers receiving 509 citations

Peers

Bhavya S. Doshi

HEMAT

GENET

NEURO

ONCOL

Ljiljana Luković Serbia

Luca Sbaiz Italy

Paul V. Dellorusso United States

J. Watt Australia

Parag Tamhankar India

Charlotta Böiers Sweden

Jennyfer Zerbib France

Michael Landowski United States

G. Salvo Italy

Isaura M. Frost United States

Ljiljana Luković Serbia

Bhavya S. Doshi

43 ×0.2

HEMAT

106 ×0.5

35 ×0.3

GENET

61 ×0.6

NEURO

38 ×0.4

ONCOL

Citations per year, relative to Bhavya S. Doshi Bhavya S. Doshi (= 1×) peers Ljiljana Luković

Countries citing papers authored by Bhavya S. Doshi

Since Specialization

Citations

This map shows the geographic impact of Bhavya S. Doshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhavya S. Doshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhavya S. Doshi more than expected).

Fields of papers citing papers by Bhavya S. Doshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhavya S. Doshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhavya S. Doshi. The network helps show where Bhavya S. Doshi may publish in the future.

Co-authorship network of co-authors of Bhavya S. Doshi

This figure shows the co-authorship network connecting the top 25 collaborators of Bhavya S. Doshi. A scholar is included among the top collaborators of Bhavya S. Doshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhavya S. Doshi. Bhavya S. Doshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doshi, Bhavya S., Robert J. Davidson, Wei Wang, et al.. (2025). Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies. Molecular Therapy. 33(7). 3073–3085. 2 indexed citations

Doshi, Bhavya S., et al.. (2025). Diagnosis of platelet dysfunction in children: clinical predictors and test methods. PubMed. 3(1). 100135–100135.

Samelson‐Jones, Benjamin J., Bhavya S. Doshi, & Lindsey A. George. (2024). Coagulation factor VIII: biological basis of emerging hemophilia A therapies. Blood. 144(21). 2185–2197. 4 indexed citations

Doshi, Bhavya S., Benjamin J. Samelson‐Jones, Timothy C. Nichols, et al.. (2024). AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life. Molecular Therapy — Methods & Clinical Development. 32(1). 101205–101205. 7 indexed citations

Doshi, Bhavya S., et al.. (2024). Success of Immune Tolerance Induction after AAV Gene Therapy in High-Responding Inhibitor Hemophilia a Dogs May be F8 Genotype Dependent. Blood. 144(Supplement 1). 3579–3579.

George, Lindsey A., Bhavya S. Doshi, Denise E. Sabatino, et al.. (2023). Coagulation factor VIII regulates von Willebrand factor homeostasis in vivo. Journal of Thrombosis and Haemostasis. 21(12). 3477–3489. 2 indexed citations

Doshi, Bhavya S., Elinor Willis, Timothy C. Nichols, et al.. (2023). Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dog. Molecular Therapy — Methods & Clinical Development. 31. 101159–101159. 5 indexed citations

Doshi, Bhavya S., et al.. (2022). Vector Analysis of Multicentric Lymphoma in a Severe Hemophilia Α Dog after AAV Gene Therapy. Blood. 140(Supplement 1). 4919–4920. 2 indexed citations

Pishko, Allyson M. & Bhavya S. Doshi. (2022). Acquired Hemophilia A: Current Guidance and Experience from Clinical Practice. Journal of Blood Medicine. Volume 13. 255–265. 20 indexed citations

10.

Doshi, Bhavya S., Giancarlo Castaman, Radosław Kaczmarek, et al.. (2021). B cell–activating factor modulates the factor VIII immune response in hemophilia A. Journal of Clinical Investigation. 131(8). 17 indexed citations

11.

Bhosale, Archana, et al.. (2020). A prospective observational study to evaluate the maternal and neonatal outcome of forceps delivery in a tertiary care government hospital. International Journal of Clinical Obstetrics and Gynaecology. 4(4). 8–11.

12.

Doshi, Bhavya S., Leslie Raffini, & Lindsey A. George. (2020). Combined anti‐CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors. Journal of Thrombosis and Haemostasis. 18(4). 848–852. 10 indexed citations

13.

Doshi, Bhavya S. & Valder R. Arruda. (2020). Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020069–e2020069. 20 indexed citations

14.

Doshi, Bhavya S., Rachel Rogers, Hilary Whitworth, et al.. (2019). Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients. Journal of Thrombosis and Haemostasis. 17(11). 1838–1847. 22 indexed citations

15.

Gollomp, Kandace, Bhavya S. Doshi, & Valder R. Arruda. (2019). Gene therapy for hemophilia: Progress to date and challenges moving forward. Transfusion and Apheresis Science. 58(5). 602–612. 26 indexed citations

16.

Doshi, Bhavya S.. (2019). Implementation of Online Portal for CV Analysis Using KNN Algorithm. International Journal for Research in Applied Science and Engineering Technology. 7(4). 1435–1439. 1 indexed citations

17.

Arruda, Valder R., Bhavya S. Doshi, & Benjamin J. Samelson‐Jones. (2017). Novel approaches to hemophilia therapy: successes and challenges. Blood. 130(21). 2251–2256. 92 indexed citations

18.

Doshi, Bhavya S., et al.. (2016). Incidence of Hemolytic Events after Exposure to Triggering Medications in Pediatric Patients with G6PD Deficiency. Blood. 128(22). 4810–4810.

19.

Doshi, Bhavya S., Bagirath Gangadharan, Christopher B. Doering, & Shannon L. Meeks. (2012). Potentiation of Thrombin Generation in Hemophilia A Plasma by Coagulation Factor VIII and Characterization of Antibody-Specific Inhibition. PLoS ONE. 7(10). e48172–e48172. 16 indexed citations

20.

Collinge, John, Jeremy M. Brown, John Hardy, et al.. (1992). INHERITED PRION DISEASE WITH 144 BASE PAIR GENE INSERTION: 2. CLINICAL AND PATHOLOGICAL FEATURES. Brain. 115(3). 687–710. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact